{
    "nct_id": "NCT03747757",
    "official_title": "Cognitive Behavioral Therapy (CBT) Intervention for Cancer Related Fatigue (CRF) in Patients With AML and Lymphoma",
    "inclusion_criteria": "* Diagnosis of AML or AML secondary to MDS (myelodysplastic syndrome) and lymphoma with fatigue >= 4/10 (0-10 scale) on the MDASI-AML/MDS.\n* Presence of fatigue for at least 2 weeks.\n* Normal cognition by Memorial Delirium Assessment Scale score of < 13 at baseline.\n* Hemoglobin > 8 g/L within 2 weeks of enrollment in the study; if the patient has not had blood drawn for a hemoglobin level in the past two weeks, one will be done to determine the eligibility.\n* Zubrod performance status =< 2.\n* Able to communicate in English or Spanish.\n* Seen at leukemia and lymphoma clinics at University of Texas (UT) MD Anderson Cancer Center, Houston, Texas and its affiliates in University of Texas.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Has received CBT (cognitive behavioral therapy) for any indication (e.g. depression, sleep disturbance) in the past 1 year.\n* Inability to comply with study protocol procedures.\n* Prior cancer diagnosis other than noted in the inclusion criterion #1.",
    "miscellaneous_criteria": ""
}